have been approved to treat renal cell carcinoma (RCC), and several other molecules are under investigation. However, lack of response to antiangiogenic drugs and adverse drug reactions leading to ...

Renal cell carcinoma accounts for about 80 percent of all renal cancer cases. They found a genetic mutation pattern called SBS12 in 72 percent of the 36 study subjects from Japan.

Kidney cancer is the seventh most commonly diagnosed cancer in the UK, and renal cell carcinoma makes up 90 per cent of cases. While much of the risk comes from lifestyle factors, genetics also plays ...

Renal cell carcinoma (RCC) exhibits distinct clinical characteristics across its histological subtypes. Clear cell RCC accounts for approximately 75% of cases while the remaining non-clear cell RCC ...

Cystic renal cell carcinoma is a predominantly cystic lesion with a small solid component (25% or less). Renal cell carcinoma usually presents as a solid mass; however, in 10–22% of cases ...

Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications.

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Kidney Cancer Session II. Dr Mark Ball discussed ...

"Among genitourinary tumors, renal cell carcinoma (RCC) has been the area of most clinical trial research into the gut microbiome since immunotherapy is a mainstay of treatment in RCC," said Ulka ...